Higher Medicine Revenue

Biotechnology Research • Maryland / Delaware, United States • 1-10 Employees

Higher Medicine revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	$100,000

Key Contact at Higher Medicine

Leo Kim

Founder & CEO

Company overview

Headquarters	Maryland / Delaware, United States
Website	highermedicine.bio
NAICS	541714
Founded	2024
Employees	1-10
Socials

About Higher Medicine

www.HigherMedicine.Bio Higher Medicine is advancing clinics-ready small molecules for pediatric and neurodegenerative disorders, starting with Kabuki syndrome and Friedreich’s ataxia. Our lead programs—an LSD1 inhibitor and a p38 MAP kinase inhibitor—are supported by substantial safety and clinical data, enabling a de-risked entry into Phase 2a trials by 2026. With $200K raised and $2.1M in soft commitments, we’re closing a $2M pre-seed round to complete IND-enabling steps. Backed by top-tier advisors and collaborators at Johns Hopkins and UPenn, we offer a capital-efficient path to near-term proof-of-concept data and long-term impact across autism, Alzheimer’s, and health span extension.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Higher Medicine has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Higher Medicine's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2025-07-05	9	$100,000

Funding Insights

$100,000

Total funding amount

$100,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Higher Medicine is located in Maryland / Delaware, US.

Higher Medicine generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

Higher Medicine has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Higher Medicine was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Higher Medicine has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Higher Medicine has raised a total of $100,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Higher Medicine

Leo Kim

Founder & CEO

4.8

40,000 users